Welford RW et al. |
Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. |
2014 |
PLoS ONE |
pmid:25479233
|
Sun Y et al. |
Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology. |
2015 |
PLoS ONE |
pmid:25822147
|
Mirzaian M et al. |
Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard. |
2015 |
Blood Cells Mol. Dis. |
pmid:25842368
|
Fuller M et al. |
Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool. |
2015 |
Clin. Chim. Acta |
pmid:26232157
|
Dasgupta N et al. |
Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model. |
2015 |
Hum. Mol. Genet. |
pmid:26420838
|
Gramlich PA et al. |
A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: Design, production, and assessment. |
2016 |
J. Biotechnol. |
pmid:26795355
|
Murugesan V et al. |
Glucosylsphingosine is a key biomarker of Gaucher disease. |
2016 |
Am. J. Hematol. |
pmid:27441734
|
Dai M et al. |
Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease. |
2016 |
PLoS ONE |
pmid:27598339
|
Kang L et al. |
Successful newborn screening for Gaucher disease using fluorometric assay in China. |
2017 |
J. Hum. Genet. |
pmid:28356566
|
Igisu H et al. |
Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids. |
1988 |
Lipids |
pmid:2840545
|
Franco M et al. |
Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease. |
2017 |
Am. J. Hematol. |
pmid:28621801
|
Taguchi YV et al. |
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease. |
2017 |
J. Neurosci. |
pmid:28847804
|
Smith NJ et al. |
Reduced cerebral vascularization in experimental neuronopathic Gaucher disease. |
2018 |
J. Pathol. |
pmid:28981147
|
Lukas J et al. |
Glucosylsphingosine Causes Hematological and Visceral Changes in Mice-Evidence for a Pathophysiological Role in Gaucher Disease. |
2017 |
Int J Mol Sci |
pmid:29053611
|
Legler G and Bieberich E |
Isolation of a cytosolic beta-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives. |
1988 |
Arch. Biochem. Biophys. |
pmid:2963589
|
Hara A and Taketomi T |
Chemical properties and stereoisomerism of heterogeneous long chain bases in lysosphingolipids by positive ion fast atom bombardment mass spectrometry and carbon-13 NMR spectroscopy. |
1986 |
J. Biochem. |
pmid:3782058
|
Nilsson O et al. |
Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants. |
1985 |
Clin. Genet. |
pmid:3924448
|
Gatt S et al. |
Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease. |
1982 |
Prog. Clin. Biol. Res. |
pmid:6812076
|
Suzuki K |
Glucosylceramide and related compounds in normal tissues and in Gaucher disease. |
1982 |
Prog. Clin. Biol. Res. |
pmid:7122635
|
Yamaguchi Y et al. |
The synthetic pathway for glucosylsphingosine in cultured fibroblasts. |
1994 |
J. Biochem. |
pmid:7852294
|